Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

If I have cancer, dementia or MS, should i get the covid vaccine?

If I have cancer, dementia or MS, should i get the covid vaccine?

Infusion of convalescent blood plasma benefits patient with severe COVID-19

Infusion of convalescent blood plasma benefits patient with severe COVID-19

MDC researchers develop a potent weapon against lymphomas

MDC researchers develop a potent weapon against lymphomas

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

Combination of venetoclax and standard therapies shows promise in high-risk myeloid blood cancers

Grants give military veterans better access to cancer clinical trials

Grants give military veterans better access to cancer clinical trials

Commonly prescribed anti-depressant may halt the growth of childhood sarcoma

Commonly prescribed anti-depressant may halt the growth of childhood sarcoma

Case study reports prolonged infectious SARS-CoV-2 shedding from an asymptomatic leukemia patient

Case study reports prolonged infectious SARS-CoV-2 shedding from an asymptomatic leukemia patient

Researchers are developing a new class of compounds against various cancers

Researchers are developing a new class of compounds against various cancers

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Researchers unravel new mechanism of cell survival in chronic lymphocytic leukemia

Researchers unravel new mechanism of cell survival in chronic lymphocytic leukemia

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

New drug can prevent life-threatening anaphylaxis, shows study

New drug can prevent life-threatening anaphylaxis, shows study

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Drug combo for untreated CLL approved by FDA based on E1912 trial

Drug combo for untreated CLL approved by FDA based on E1912 trial

Greater occurrence of infections correlates with future cancer diagnosis

Greater occurrence of infections correlates with future cancer diagnosis